Tripos Announces Release of Benchware 3D Explorer 2.2; Visualization Platform Allows Laboratory Scientists to Make More Efficient Decisions Based on Three-Dimensional Molecular Information
Tripos, Inc., a leading provider of drug discovery informatics products and chemistry research, today announced the release of Benchware(R) 3D Explorer 2.2, an enhanced version of its premier application for the communication of 3-D chemical information. Benchware 3D Explorer empowers laboratory scientists to make more effective research decisions by allowing them to visualize, annotate, share and experiment with 3-D chemical structural information and the results of computational research.
“We place a great deal of importance on our ability to visualize and understand the chemistries we are exploring,” said Dr. Philippe Guedat, head of chemistry at Hybrigenics S.A., a pathway-based drug discovery company. “Benchware 3D Explorer’s high-quality graphics, advanced molecular editing functionality and powerful communication capabilities allow us to make better use of the information produced within our own drug discovery programs and arising from our novel fee-for-service high-throughput screening activity. This leads to better-informed decisions at the bench.”
With this release, Benchware 3D Explorer now supports visualization of pharmacophore models and 3-D molecular queries, improving the communication and analysis of vital structural information over all types of discovery projects. Expanded representation of chemical structures and molecular interactions, as well as workflow enhancements, enables users to more quickly and easily reach key decisions. Benchware 3D Explorer’s VBA scripting environment is also now included as a standard feature in the application, allowing power users to create and deploy task-specific applications throughout the organization.
“With the new enhancements, laboratory scientists now have greater access to all forms of 3-D information, including an improved ability to visualize structural commonalities between active molecules,” said Dr. David Lowis, senior director of product management at Tripos. “By using Benchware 3D Explorer as their visualization and decision support tool, drug discovery chemists can now ‘see,’ in real time, how changes to their proposed syntheses may affect important molecular properties. Insights made in this fashion can also be easily shared with colleagues using the application’s communication functionality.”
Customers wishing to acquire a free evaluation copy of Benchware 3D Explorer may do so at http://www.tripos.com/download . Benchware 3D Explorer was formerly marketed by the trade name LITHIUM(R).
About Tripos, Inc.
Tripos (Nasdaq:TRPS) combines leading-edge technology and innovative science to deliver consistently superior chemistry-research products and services for the biotechnology, pharmaceutical and other life science industries. Within Tripos’ Discovery Informatics (DI) business, the company provides software products and consulting services to develop, manage, analyze and share critical drug discovery information. Within Tripos’ Discovery Research (DR) business, Tripos’ medicinal chemists and research scientists partner directly with clients in their research initiatives, leveraging state-of-the-art information technologies and research facilities. Headquartered in St. Louis, Mo., Tripos spans the world with global research operations and an international client base. Further information on Tripos can be found at http://www.tripos.com .
Tripos and the Tripos logo are registered trademarks of Tripos, Inc., and/or its affiliates in the United States and certain other countries. All other trademarks mentioned in this document are the property of their respective owners.
